Sir,

I read with interest the case report by Kumar *et al*. on the hypothyroid infant with diffuse scalp hair loss due to levothyroxine overdose.\[[@ref1]\] Although the authors addressed a causal relationship between the occurrence of alopecia and starting levothyroxine therapy based on clinical and biochemical responses, I presume that they should consider the following point which might significantly add to the development of alopecia in the case in question. It is obvious that Zinc (Zn) is an essential element for maintaining human body homeostasis and it is one of the major constituents of hormones, signal molecules, and enzymes. On one hand, marked alterations in Zn homeostasis in persons with thyroid disease is well established. Plasma Zn was found to be lower in hypothyroid subjects and correlated with serum albumin. Peripheral blood mononuclear cell Zn and urinary Zn were also found to be low in such patients.\[[@ref2]\] On the other hand, Zn was noticed to help recover appropriate activities of metalloenzymes, hedgehog signaling, and immunomodulation, all of which are required for the normal control of hair growth cycle.\[[@ref3]\] Apart from the levothyroxine-associated alopecia, I presume that concomitant Zn deficiency ought to be additionally considered in hypothyroid patients with alopecia as such association has been rarely reported in the literature.\[[@ref4]\]
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